Ikarian Capital, LLC Allovir, Inc. Transaction History
Ikarian Capital, LLC
- $640 Million
- Q3 2025
A detailed history of Ikarian Capital, LLC transactions in Allovir, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 200,000 shares of ALVR stock, worth $1.96 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
200,000Holding current value
$1.96 Million% of portfolio
0.16%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ALVR
# of Institutions
3Shares Held
727KCall Options Held
0Put Options Held
0About Allovir, Inc.
- Ticker ALVR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,063,400
- Market Cap $913M
- Description
- Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...